NeuroPace (NPCE) Cash & Current Investments (2020 - 2026)
NeuroPace (NPCE) posted quarterly Cash & Current Investments of $54.0 million for Q1 2026, down 18.53% year-over-year from $66.3 million in Q1 2025, and down 11.59% quarter-over-quarter from $61.1 million in Q4 2025.
NeuroPace (NPCE) Cash & Current Investments (2020 - 2026) Analysis & Trends
NeuroPace's Cash & Current Investments history runs 7 years deep, the most recent figure standing at $54.0 million for Q1 2026.
- In Q1 2026, Cash & Current Investments fell 18.53% year-over-year to $54.0 million; the TTM figure through Mar 2026 stood at $54.0 million (down 18.53% YoY), while the FY2025 annual figure was $61.1 million, up 15.74% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $54.0 million, down from $61.1 million in the prior quarter.
- The five-year high for Cash & Current Investments was $103.2 million in Q1 2022, with the low at $52.8 million in Q4 2024.
- The 5-year median for Cash & Current Investments is $62.1 million (2025), against an average of $67.3 million.
- The sharpest annual moves came in 2022 and 2023: Cash & Current Investments jumped 237.95% in 2022, then plunged 34.47% in 2023.
- NeuroPace's Cash & Current Investments stood at $77.4 million in 2022, then retreated by 14.15% to $66.5 million in 2023, then dropped by 20.61% to $52.8 million in 2024, then grew by 15.74% to $61.1 million in 2025, then slipped by 11.59% to $54.0 million in 2026.
- Business Quant data shows NPCE's Cash & Current Investments at $54.0 million in Q1 2026, $61.1 million in Q4 2025, and $60.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | NeuroPace | 463.82 Mn | 412.12 Mn | 18.91 Mn | 51.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.70 Mn |
| Mar 31, 2026 | 53.98 Mn |
| Dec 31, 2025 | 61.06 Mn |
| Sep 30, 2025 | 60.01 Mn |
| Jun 30, 2025 | 62.14 Mn |
| Mar 31, 2025 | 66.26 Mn |
| Dec 31, 2024 | 52.76 Mn |
| Sep 30, 2024 | 56.83 Mn |
| Jun 30, 2024 | 55.54 Mn |
| Mar 31, 2024 | 58.95 Mn |
| Dec 31, 2023 | 66.45 Mn |
| Sep 30, 2023 | 61.35 Mn |
| Jun 30, 2023 | 63.57 Mn |
| Mar 31, 2023 | 67.62 Mn |
| Dec 31, 2022 | 77.41 Mn |
| Sep 30, 2022 | 85.41 Mn |
| Jun 30, 2022 | 92.41 Mn |
| Mar 31, 2022 | 103.18 Mn |
| Dec 31, 2021 | 115.58 Mn |
| Sep 30, 2021 | 123.33 Mn |